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Chloracne is the most sensitive and speciﬁc marker for a possible dioxin (2,3,7,8-tetrachlorodibenzo-p-
dioxin) intoxication. It is clinically characterized by multiple acneiform comedone-like cystic eruptions
mainly involving face in the malar, temporal, mandibular, auricular/retroauricular regions, and the
genitalia, often occurring in age groups not typical for acne vulgaris. Histopathology is essential for
a deﬁnite diagnosis, which exhibits atrophy or absence of sebaceous glands as well as infundibular
dilatation or cystic formation of hair follicles, hyperplasia of epidermis, and hyperpigmentation of
stratum corneum. The appearance of chloracne and its clinical severity does not correlate with the blood
levels of dioxins. Pathogenesis of chloracne remains largely unclear. An “aryl hydrocarbon receptor”-
mediated signaling pathway affecting the multipotent stem cells in the pilosebaceous units is probably
the major molecular mechanism inducing chloracne. Chloracne is resistant to all the available treatment
modalities used to treat acne. The aim of treatment is to lower or to eliminate the accumulated dioxins in
the body at the very beginning of intoxication, e.g., by using dioxin-chelating substances such as
synthetic dietary fat substitutes. The problem of dioxin contamination and its potential health hazards
should be taken seriously in the wave of industrial globalization in the twenty-ﬁrst century. Clinicians,
especially dermatologists, are in the forefront of early diagnosis of dioxin intoxication.
Copyright  2012, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Chemically induced acne is a group of disorders characterized by
the formation of acne-like lesions in previously acne nonprone
patients after exposure to chemical compounds.1 It includes acne
venenata/acne cosmetica, oil acne, coal-tar acne and chloracne.
Chloracne is mostly caused by compounds containing poly-
halogenated naphthalenes, polyhalogenated biphenyls, poly
chlorophenols, 3,4 dichloroanilines and especially 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD).1 These chloracnegens are
structurally similar, containing two benzene rings with halogen
atoms occupying at least three of the lateral ring positions.1
Chloracne can be diagnosed by the history of exposure to chlor-
acnegens, characteristic clinical manifestations such as acutely
emerging comedones, papules, nodules, and cysts followed by scar
and speciﬁcally the detection of high serum concentration oftment of Dermatology and
er Strasse 29, 80802 Munich,
en).
iwanese Dermatological Associatiochloracnegens.1,2 As assessment of chloracnegens in serum can only
be carried out in specialized laboratories and the serum titers of
dioxins are usually within the normal range; histopathologic
changes also offer important clues in the diagnosis of chloracne.2,3
Epidemiology of chloracne
Chloracne was ﬁrst described by von Bettman in 1897 and the term
proposed by Herxheimer in 1899.4 Since then, there are several
large accidents caused by occupational exposures or food
contaminations.1,5 After the second World War, several episodes of
large-scale dioxin poisoning (Ludwigshafen/Germany, Amsterdam/
Netherlands, Fukuoka/Japan, Seveso/Italy, Changhua/Taiwan) were
reported each with more than 100 victims (Table 1).5e10 Massive
intoxication had so far happened twice through ingestion of
contaminated oils, “Yusho” in Fukuoka/Kyushu/Japan in 1968 and
“Yu-Cheng” in Changhua/Taiwan in 1979 (Figure 1), both terms
meaning “oil syndrome.” The real prevalence of chloracne among
Vietnamese civilians and American soldiers caused by agent orange
(containing phenoxyl herbicide contaminated with dioxins) is
unknown.11 The identiﬁcation of dioxin as elicitor of chloracne wasn. Published by Elsevier Taiwan LLC. All rights reserved.





Pollutants Occurrence Long-term follow-up of
chloracne prevalence
References
1953 Germany/Ludwigshafen 247 TCP/TCDD Leakage of byproducts of TCP
production from a chemical reactor
10.1% (survey in 1989) 6
1963 Netherlands/Amsterdam 145 TCDD Explosion of a factory producing
crop-protection agents
48.9% (survey in 1983) 7
1968 Japan/Kyushu (Fukuoka, Nagasaki) 1,684 PCB Contamination of PCB in rice bran
oil
7.8% (survey in 1993) 8
1976 Italy/Seveso 193* TCP/TCDD Explosion of a TCP reactor 1/193 (survey in 1989) 9
1979 Taiwan/Changhua, Taichung 2,061 PCB Contamination of PCB in rice bran
oil
17% (survey in 1993) 10
PCB¼ polychlorinated biphenyls; TCDD¼ 2,3,7,8-tetrachlorodibenzo-p-dioxin; TCP¼ trichlorophenol.
* 193 detected cases with chloracne (170 younger than 15 years of age).
Q. Ju et al. / Dermatologica Sinica 30 (2012) 2e6 3made by cooperation between dermatologists K.H. Schulz and
J. Kimmig with the chemist G. Sorge in Hamburg, Germany, who
investigated patients with atypical acne in a chemical plant.12 Due
to its extensive long-term developmental and neurological toxicity,
hormonal and immunologic disruption as well as cancer promo-
tion, the production of polychlorinated biphenyls has been pro-
hibited by the Stockholm Treaty on Persistent Organic Pollutants
passed in 2004.13 The most recent sensational case report of
chloracne incident was about the TCDD poisoning of Viktor
Andriyovych Yushchenko, a former president of Ukraine in late
December 2004.14
Clinical picture of chloracne
The typical manifestation of chloracne begins with multiple
acneiform comedone-like lesions that may further form inﬂam-
matory nodules/cysts and noninﬂammatory straw-colored
“epidermal” cysts, involving preferentially the face in the peri-
orbital overlying os zygomaticum, malar, temporal, mandibular and
auricular/retroauricular regions (Figure 2). Concurrence with
comedones and some inﬂammatory papulopustules is usually
observed in adults but it is unclear if these are real acne lesions. Any
part of the body, including the genitalia and the limbs, can be
affected and atrophic scar is a common late sequela.10,15 Differen-
tiation from acne vulgaris in the early phase of outbreak can be
challenging. The simultaneous appearance of cutaneous hyper-
pigmentation and conjunctival discharge (defective meibomian
glands) is a useful diagnostic sign. Chloracne can develop soon, e.g.,
in a few weeks, after exposure to chloracnegens.16 In general, the
clinical manifestation is not very diagnostic and a histologicFigure 1 A baby born to a polychlorinated biphenyls-intoxicated mother in Taiwan
during the Yu-Cheng disaster in 1979, with generalized brownish hyperpigmentation
(the so-called cola-babies), hepatomegaly and abnormal dental development.examination is required in isolated suspected cases. A detailed
medical history, especially an inquiry about clustering of similar
cases in the workplaces or at home, is necessary. Occurrence of
monomorphous acneiform lesions beyond the “acne age,” e.g., in
the childhood, should also raise special attention, because the
chloracnegens especially dioxins can pass via placenta or breast
milk and induce chloracne without direct exposure.17
Histopathology of chloracne
The histopathology of chloracne is characterized mainly by mini-
ature to absent sebaceous glands, accompanied by hyperplasia of
epidermis and hyperpigmentation of stratum corneum. In addition,
follicular hyperkeratosis with orthokeratosis, infundibular dilata-
tion, and infundibular cysts can be detected. Occasionally, inﬂam-
matory inﬁltrate, solar elastosis, and thinning of the follicular wall
with cicatricial atrophy can be found.18 The histopathologic features
of chloracne lesions have been systematically evaluated both in
human volunteers,19 in hairless micemodel,20 and in ex vivo human
skin studies.21 In early lesions, the epithelial cells of the outer root
sheath formed thewall of the proximal portion of the infundibulum
resulting in dilatation of the proximal infundibulum. The walls of
the sebaceous glands are thickened and merged with the follicular
infundibular wall. Hyperplasia of the epidermal keratinocytes with
incomplete keratinization is indicated by a thick, parakeratotic cell
layer surrounding a mass of keratinized epidermal cells, which
begins a proximal ﬁlling of the infundibulum. In later stage lesions,Figure 2 A victim of the cooking oil contamination with polychlorinated biphenyls
(Yu-Cheng) occurring in Changhua Taiwan in 1979. There are multiple noninﬂamma-
tory cystic-like lesions and comedones on the face and nasal ridges. Hyperplasia of the
meibomian glands with hypersecretion is usually seen inside the tarsal plates of the
lower eyelid.
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diminution of the sebaceous glands with reduced numbers of cells
and reduced size of sebaceous lobules with in a normal appearance
can be detected. Lesions at the later stage consist of small come-
dones with nearly all of the vellus hair follicles with a thickening of
the outer root sheath, dilated infundibula ﬁlled with sebum, and
absence of sebaceous lobules. In addition, a few cases of chloracne
were observed with numerous tiny infundibular cysts instead of
comedones representing the major lesions of chloracne without
squamous metaplasia of the sebaceous glands or ducts.18,22
Pathogenesis of chloracne
Pathogenesis of chloracne remains incompletely understood. With
the disappearance instead of hypertrophy of sebaceous glands,
chloracne is actually not acne and the term is a misnomer.3 The
minimum threshold value of dioxin inducing chloracne is poorly
deﬁned. On the other hand, the clinical severity of chloracne is not
always correlated with the blood level of dioxin.23 In general,
chloracne is absent when serum chloracnegens below 1,000 pg
TEQ (TCDD-toxic-equivalent)/g lipid weight but can be observed
with TEQ/g above 10,000 pg/g lipid weight.3 However, chloracne
can occur even the serum TEQ values are in the normal range, i.e.,
5.39 pg TEQ/g lipid weight.18 Due to its high lipophilicity, the
median half-life of dioxins was estimated to be 2.9 years in the ﬁrst
15 years after intoxication and 7.7 years in the next stage of 15
years.24 As the major histopathologic characteristic of chloracne is
hyperplasia of epidermal cells with atrophy and replacement of
the sebaceous glands and ducts by keratinized epidermal cells,
this indicates different epithelial structures in the skinmay respond
differentially to chloracnegens. Earlier studies have reported that
sebaceous glands are replaced by keratinized epithelial cells
because sebaceous glands undergo squamous metaplasia and
keratinization in patients with chloracne.25 However, as epidermal
progenitor cells in the bulge region of the hair follicle give rise
to multiple skin lineages, including hair follicles, sebaceous
glands, and the interfollicular epidermis,26 it is hypothesized that
chloracnegen-induced transformation of the pilosebaceous unit is
driven by activation and accelerated exit of cells from the stem cell
compartment coupled with a shift from a pilosebaceous differen-
tiation pattern to an epidermal one.27 This may result in imbalance
between early multipotent cells commitment and their preferential
differentiation along an epidermal lineage with consequent
diminution of sebaceous gland and lower hair follicle portion
along with prominent epidermal/infundibular hyperplasia and
hyperkeratinization.
Mechanisms of the effects of dioxins on keratinocyte differen-
tiation are still controversial. Topical application of TCDD in adult
hairless mice resulted in hyperkeratinization and induction of
mouse dermal cyst, whereas the interfollicular epidermis was not
affected.28 Exposure of murine fetuses in utero to TCDD led to an
accelerated terminal differentiation of fetal skin.29 A survey of 23
cell lines displayed no changes in morphology, viability, or growth
patterns following treatment with TCDD.30 Furthermore, TCDD
caused the acceleration of differentiation of a spontaneously
immortalized human keratinocyte cell line in a three-dimensional
skin equivalent model as determined by morphologic character-
ization and by immunohistochemistry for several differentiation-
speciﬁc protein markers. Neither an inﬂuence on proliferation nor
an induction of apoptosiswas observed.31 TCDDwas found to impair
differentiation of normal human epidermal keratinocytes in a skin
equivalent model.32 Thus most of the studies proved that TCDD
exerts profound effects on keratinocyte differentiation in vitro
in organotypic cultures but not in monolayer cultures. A recent
in vitro study using normal human epidermal keratinocytes showeda TCDD-mediated aryl hydrocarbon receptor (AhR)-dependent
acceleration of differentiation and increase in gene expression of
several prodifferentiation genes, including ﬁlaggrin and small
proline rich protein 2, indicating the epidermal permeability barrier
is also a functional target of the TCDD-activated AhR.33
As the differentiation of sebocytes is severely affected following
dioxin exposure in vivo and markedly reduced sebum levels with
skin xerosis is an important clinical feature of chloracne,34 the
effects of dioxins on sebaceous glands are especially interesting and
important. TCDD exhibits an inhibitory effect on lipid metabolism
in laboratory rodents and humans and induces clinically a wasting
syndrome.35 The use of animal models such as that of the rabbit
ear,36 meibomian glands of primates,37 and hairless mice has
shown that miniaturization of sebaceous glands is noted following
TCDD exposure.20 It has recently been proven that TCDD decreased
lipogenesis and affected differentiation of human sebaceous gland
cells by switching the sebaceous into a keratinocyte-like differen-
tiation in cultured SZ95 sebocytes and in human skin maintained
ex vivo.21
Most of the effects of TCDD in humans and animals appear to be
mediated by the AhR signaling pathway, a member of the basic-
helix-loop-helix period-ARNT-single-minded (Per-ARNT-Sim)
family of dimeric transcription factors.38 AhR was previously found
to be expressed and activated in human keratinocytes and skin
ﬁbroblasts as well as in human sebaceous glands and human
immortalized SZ95 sebocytes.21,39,40 In the skin lesions of chloracne
patients exposed to dioxin, there was an activation and upregula-
tion of p- epidermal growth factor receptor EGFR (EGFR), p-
mitogen-activated protein kinase, and CK17 in all chloracne tissues
but not in the controls, while transglutaminase 1 showed distinct
distribution patterns.41 Furthermore, an increase in the dioxin-
independent transcriptional activity of the AhR has recently been
demonstrated in a Drosophila model to be also responsible for the
in vivo dioxin toxicity.42
The speciﬁc histologic changes of chloracne can be rationally
explained by the hypothesis based on stem-cell theory. Down-
streammolecular targets of AhR are versatile including inﬂuence of
classical xenobiotic metabolizing enzymes (such as CYP1A1 and
CYP1A2), interleukin-1b, tumor growth factors, c-Myc, EGFRs, and
B lymphocyte maturation protein 1 (Blimp1, a negative regulator of
c-Myc, reported in sebocytes recently).40 Among these molecular
targets of AhR, c-Myc and Blimp1 are supposed to play an impor-
tant role in modulating directional differentiation of epidermal
progenitor cells and be a potential important target linkage
between speciﬁc TCDD-induced skin pathology and the stem-cell
differentiation changes in the skin. Activation of c-Myc favors
differentiation along the lineages of the interfollicular epidermis
and sebaceous gland, and it results in the appearance of groups of
differentiated sebocytes within the interfollicular epidermis.43
Inactivation of c-Myc results in hypoplasia of the sebaceous
glands.44 Loss of Blimp1 results in the elevation of c-Myc expres-
sion and hyperplasia of the sebaceous glands.45 Taken together,
TCCD/AhR/ARNT/Blimp1 and CYP1A1/c-Myc pathways may very
likely be the proposed signaling pathways of TCDD on skin stem-
cell progenitors, leading to TCDD-induced abnormal differentia-
tion of sebaceous gland (Figure 3).21
Treatment of chloracne
Although some individual reports showed that retinoids,46,47
dermabrasion, and light electrodesiccation may be useful in the
treatment of chloracne,48 chloracne actually appears to be resistant
to all tested forms of treatment.23,49 Therefore, the only way to
manage chloracne is to prevent exposure to chloracnegens.47 Once
exposure happens, affected individuals should be removed from
Figure 3 Proposed signaling pathway of 2,3,7,8-tetrachlorodibenzo-p-dioxin activity
in human sebocytes. Reprinted with permission from Experimental Dermatology
(Wiley-Blackwell, New Jersey, USA).
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the body should be performed. Recently, a synthetic dietary fat
substitute, known as olestra, could bind to chloracnegens and
accelerate their fecal excretion.50 A further study has showed that
combined dietary olestra and caloric restriction causes a 30-fold
increase in the rate of excretion of labeled compound,51 which
may be a prospective therapeutic method in the future.
Conclusions
The rash globalization and boosting of economic growth, espe-
cially in the newly industrialized countries, with improper
manufacturing, handling and disposal of, for example electronic
waste, may well lead to the propagation, accumulation, and
augmentation of the long-persisting toxicity of dioxins, conse-
quently resulting in potential serious threatening health haz-
ards.52e54 More than 110 years after its ﬁrst description, chloracne
remains the most sensitive and speciﬁc clinical indicator of
systemic poisoning by dioxins and other polyhalogenated (poly-
chlorinated) aromatic hydrocarbons. Since the clinical diagnosis of
chloracne without histopathology may not be straightforward and
the laboratory quantiﬁcation of dioxin level is intricate, clinicians,
particularly dermatologists, should keep in mind the possible
encounter with chloracne in their daily practice. A better under-
standing of the pathogenesis of chloracne may help in the devel-
opment of more speciﬁc and effective treatments.
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